A61M5/2046

A SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICE
20170239427 · 2017-08-24 · ·

For use in an injection device, e.g., an auto-injector of any type, a sleeve which holds the medicament chamber is sufficiently deformable that it functions as a shock absorbing member to distribute the force exerted on the medicament chamber during use of the injection device.

RETRACTABLE NEEDLE SYRINGE

A pneumatically activated retractable-needle syringe comprising a syringe barrel, a plunger, a needle, a needle hub, a locking tip, a propellant gas release cell and a rupture mechanism is provided. The plunger is slidably disposed within and sealingly engaged with the syringe barrel, the plunger having a retraction lumen defined for receiving a needle when the retractable-needle syringe is actuated. The needle is coupled to a distal end of the syringe barrel and in fluid communication with a medicament chamber defined within the syringe barrel distally of the plunger. The needle hub is for securing the needle at the distal end of the syringe barrel, the needle hub being initially secured within a false wall against a loading force or an injection force applied by a user, and releasable from the false wall in response to a post-injection force applied by a user. The locking tip is provided at a distal end of the plunger, the locking tip being in sealing engagement with and initially secured within the retraction lumen against a loading force or an injection force applied by a user, and releasable for sliding retraction within the plunger lumen in response to release of propellant upon a post-injection force applied by a user, the locking tip being engageable with the needle hub in response to the post-injection force to provide a retraction assembly comprising the locking tip, the needle header, and the needle. The propellant release cell is positioned distally of the needle hub and contains a propellant. The rupture mechanism is positioned to puncture the propellant release cell in response to the application of the post-injection force by a user to thereby drive retraction of the retraction assembly within the retraction lumen.

Intradermal injector

An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.

Injectable controlled release composition comprising high viscosity liquid carrier

Compositions may include a pharmaceutical active agent, a high viscosity liquid carrier material (HVLCM), a lactic acid-based polymer, and an organic solvent. Related compositions and methods are also disclosed. For instance, a carrier formulation for controlled release of injectable drugs is disclosed. The formulation may include a non-water soluble high viscosity liquid which may be sucrose acetate isobutyrate, a lactic-acid based polymer which may be a poly(lactic acid)(glycolic acid), and an organic solvent which maintains the composition in a monophasic form at 25° C. in one atmosphere. Drug in the formulation may be released upon administration such that less than 10% (e.g. 2-8%) of drug is released in the first 5 hours; 10% to 80% of the drug is released during a period of 5 hours to 7 days after administration; and 10% to 40% of the drug is released gradually over a period of 7 days to 28 days from initial administration. The drug may be an anti-schizophrenia agent delivered by injection.

Devices, systems and methods for medicament delivery

Apparatuses for automatic medicament injection and methods for manufacturing automatic medicament injectors are described herein. In some embodiments, an apparatus includes a housing, a needle, an energy storage member, an actuator, a locking member, and a needle guard. The needle is configured to move between a first position and a second position. In its first position, the needle is contained within the housing. In its second position, at least a portion of the needle extends from the housing. The energy storage member has a first configuration and a second configuration and is configured to produce a force when moving between its first configuration and its second configuration to move the needle from its first position to its second position. The actuator is configured to move the energy storage member from its first configuration to its second configuration. The locking member is movably coupled to the distal end portion of the housing such that the locking member can be moved between a first position and a second position. In its first position, the locking member is configured to engage the actuator to prevent the actuator from moving the energy storage member to the second configuration. The needle guard is removably coupled to at least one of the distal end portion of the housing or a base movably coupled to the distal end portion of the housing.

Devices, systems, and methods for medicament delivery

Certain exemplary embodiments comprise can comprise an auto-injector, which can comprise: a vial configured to store and/or contain an injectable medicament, the vial defining a vial longitudinal axis, and a housing comprising the vial. In various embodiments, the injectable medicament can be a medicine, medication, drug, pharmaceutical, prescriptive, agent, antidote, anti-venom, hormone, stimulant, vasodilator, anesthetic, and/or nutritional supplement that is substantially ready for injection.

NEEDLE-FREE INJECTION DEVICE COMPRISING A MEMBRANE
20170216530 · 2017-08-03 ·

The invention relates to a needleless injection device, containing at least one membrane, or a corresponding device for needleless injection of a substance, having at least one membrane, with which a powdered, gel-like or liquid agent, in particular an active agent, can be injected in a needleless manner into a tissue or a body by means of high impact speed. The invention also relates to a method for such a needleless injection device containing a membrane, and use thereof.

SPILL-RESISTANT FLUID DELIVERY DEVICE
20170274399 · 2017-09-28 · ·

An orientation independent delivery device. The delivery device includes a gas chamber, a delivery chamber, a gas cell, and a delivery aperture. The gas chamber includes a gas-side rigid portion and a gas-side flexible barrier. The gas-side flexible barrier is sealed to the gas-side rigid portion. The delivery chamber includes a delivery-side rigid portion and a delivery-side flexible barrier. The delivery-side flexible barrier is sealed to the delivery-side rigid portion and is oriented adjacent to the gas-side flexible barrier. The gas cell is coupled to the gas-side rigid portion of the gas chamber. The gas cell increases a gas pressure within the gas chamber to expand the gas-side flexible barrier. Expansion of the gas-side flexible barrier applies a compressive force to the delivery-side flexible barrier allowing a delivery material to escape from the delivery chamber.

Medicament delivery device for administration of opioid antagonists including formulations for naloxone

Medicament delivery devices for administration of opioid antagonists are described herein. In some embodiments, an apparatus includes a housing, a medicament container disposed within the housing and an energy storage member disposed within the housing. The medicament container is filled with a naloxone composition that includes naloxone or salts thereof, a tonicity-adjusting agent, and a pH-adjusting agent, whereby the osmolality of the naloxone composition ranges from about 250-350 mOsm and the pH ranges from about 3-5. The energy storage member is configured to produce a force to deliver the naloxone composition.

Gas syringe filling device and methods for making and using them

Systems and methods are provided for filling syringes, e.g., for use during pneumatic retinopexy or other medical procedures. In one embodiment, the system includes a housing carrying a gas canister including an outlet communicating with a fluid path extending from the outlet to a syringe cavity. A syringe includes a barrel receivable in the syringe cavity such that a port of the barrel communicates with the fluid path. An actuator is provided on the housing for selectively opening the outlet of the gas canister to deliver gas therein along the fluid path into the interior of the barrel, thereby causing the plunger to move from a distal position to a proximal position.